Skip to main content
Top
Published in: BMC Gastroenterology 1/2022

Open Access 01-12-2022 | Ulcerative Colitis | Research

Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study

Authors: Mohamed Negm, Ahmed Bahaa, Ahmed Farrag, Rania M. Lithy, Hedy A. Badary, Mahmoud Essam, Shimaa Kamel, Mohamed Sakr, Waleed Abd El Aaty, Mostafa Shamkh, Ahmed Basiony, Ibrahim Dawoud, Hany Shehab

Published in: BMC Gastroenterology | Issue 1/2022

Login to get access

Abstract

Background

Intermittent fasting (IF) during the month of Ramadan is part of the religious rituals of Muslims. The effect of intermittent fasting on disease activity in inflammatory bowel diseases (IBD) is still unknown. This is the first study to assess the effect of IF during Ramadan on inflammatory markers in patients diagnosed with IBD. The effects on clinical disease activity, quality of life, and levels of depression were also assessed.

Methods

Patients diagnosed with ulcerative colitis (UC) or Crohn’s disease (CD) who intended to observe Ramadan fasting were recruited. The following were assessed immediately before and at the end of Ramadan: Serum CRP and stool calprotectin, partial Mayo score, Harvey Bradshaw index (HBI), Simple IBD questionnaire (SIBDQ), and Hamilton depression scale questionnaire.

Results

80 patients diagnosed with IBD were recruited (60 UC, 20 CD). Serum CRP and stool calprotectin did not show a significant change before vs after fasting (median CRP 0.53 vs 0.50, P value = 0.27, Calprotectin 163 vs 218 respectively, P value = 0.62). The partial Mayo score showed a significant rise after fasting (median 1 before vs 1 after fasting, mean: 1.79 vs 2.33 respectively, P value = 0.02). Harvey-Bradshaw index did not show a significant change after fasting (median 4 vs 5, P value = 0.4). Multiple linear regression revealed that older age and a higher baseline calprotectin were associated with a higher change in Mayo score after fasting (P value = 0.02 and P value = 0.01, respectively). No significant change was detected in SIBDQ or Hamilton depression scale scores.

Conclusions

In patients diagnosed with UC, IF during Ramadan was associated with worsening of clinical parameters, the effect was more pronounced in older patients and those with higher baseline calprotectin levels. However, IF during Ramadan was not associated with an adverse effect on objective inflammatory markers (CRP and calprotectin).
Literature
1.
go back to reference Ismail S, Manaf RA, Mahmud A. Comparison of time-restricted feeding and Islamic fasting: a scoping review. East Mediterr Health J. 2019;25(4):239–45.PubMedCrossRef Ismail S, Manaf RA, Mahmud A. Comparison of time-restricted feeding and Islamic fasting: a scoping review. East Mediterr Health J. 2019;25(4):239–45.PubMedCrossRef
2.
go back to reference Patterson R, Sears D. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr. 2017;37(1):371–93.PubMedCrossRef Patterson R, Sears D. Metabolic Effects of Intermittent Fasting. Annu Rev Nutr. 2017;37(1):371–93.PubMedCrossRef
3.
go back to reference de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381:2541–51.PubMedCrossRef de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med. 2019;381:2541–51.PubMedCrossRef
4.
go back to reference Anton SD, Moehl K, Donahoo WT, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity. 2018;26:254–68.PubMedCrossRef Anton SD, Moehl K, Donahoo WT, et al. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity. 2018;26:254–68.PubMedCrossRef
5.
go back to reference Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011;35:714–27.CrossRef Harvie MN, Pegington M, Mattson MP, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond). 2011;35:714–27.CrossRef
6.
go back to reference Nakamura Y, Walker BR, Ikuta T. Systematic review and meta-analysis reveals acutely elevated plasma cortisol following fasting but not less severe calorie restriction. Stress. 2015;19:1–21. Nakamura Y, Walker BR, Ikuta T. Systematic review and meta-analysis reveals acutely elevated plasma cortisol following fasting but not less severe calorie restriction. Stress. 2015;19:1–21.
7.
go back to reference Kahraman S, Dogan A. Ventricular arrhythmia linked to long intermittent fasting. J Electrocardiol. 2020;58:125–7.PubMedCrossRef Kahraman S, Dogan A. Ventricular arrhythmia linked to long intermittent fasting. J Electrocardiol. 2020;58:125–7.PubMedCrossRef
8.
go back to reference Faris MAE, Madkour MI, Obaideen AK, et al. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals. Diabetes Res Clin Pract. 2019;153:166–75.PubMedCrossRef Faris MAE, Madkour MI, Obaideen AK, et al. Effect of Ramadan diurnal fasting on visceral adiposity and serum adipokines in overweight and obese individuals. Diabetes Res Clin Pract. 2019;153:166–75.PubMedCrossRef
9.
go back to reference Faris MA, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32:947–55.PubMedCrossRef Faris MA, Kacimi S, Al-Kurd RA, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32:947–55.PubMedCrossRef
10.
go back to reference Adawi M, Damiani G, Bragazzi N, et al. The impact of intermittent fasting (Ramadan fasting) on psoriatic arthritis disease activity, enthesitis, and dactylitis: a multicentre study. Nutrients. 2019;11(3):601.PubMedCentralCrossRef Adawi M, Damiani G, Bragazzi N, et al. The impact of intermittent fasting (Ramadan fasting) on psoriatic arthritis disease activity, enthesitis, and dactylitis: a multicentre study. Nutrients. 2019;11(3):601.PubMedCentralCrossRef
11.
go back to reference Ben Nessib D, Maatallah K, Ferjani H, et al. Impact of Ramadan diurnal intermittent fasting on rheumatic diseases. Clin Rheumatol. 2020;39:2433–40.PubMedCrossRef Ben Nessib D, Maatallah K, Ferjani H, et al. Impact of Ramadan diurnal intermittent fasting on rheumatic diseases. Clin Rheumatol. 2020;39:2433–40.PubMedCrossRef
12.
go back to reference Tavakkoli H, Haghdani S, Emami M, et al. Ramadan fasting and inflammatory bowel disease. Indian J Gastroenterol. 2008;27:239–41.PubMed Tavakkoli H, Haghdani S, Emami M, et al. Ramadan fasting and inflammatory bowel disease. Indian J Gastroenterol. 2008;27:239–41.PubMed
13.
go back to reference El Mountassir M, Benelbarhdadi I, Borahma M, et al. Impact of Ramadan on Crohn’s disease. Gastroenterol Hepatol Endosc. 2021;6:1–2. El Mountassir M, Benelbarhdadi I, Borahma M, et al. Impact of Ramadan on Crohn’s disease. Gastroenterol Hepatol Endosc. 2021;6:1–2.
16.
go back to reference Lewis J, Chuai S, Nessel H, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.PubMedCrossRef Lewis J, Chuai S, Nessel H, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.PubMedCrossRef
17.
19.
go back to reference Jowett SL, Seal CJ, Barton JR, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96:2921–8.PubMedCrossRef Jowett SL, Seal CJ, Barton JR, et al. The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis. Am J Gastroenterol. 2001;96:2921–8.PubMedCrossRef
21.
go back to reference Obeid S, Abi Elias Hallit C, Haddad C. Validation of the Hamilton Depression Rating Scale (HDRS) and sociodemographic factors associated with Lebanese depressed patients. Encephale. 2018;44:397–402.PubMedCrossRef Obeid S, Abi Elias Hallit C, Haddad C. Validation of the Hamilton Depression Rating Scale (HDRS) and sociodemographic factors associated with Lebanese depressed patients. Encephale. 2018;44:397–402.PubMedCrossRef
22.
go back to reference Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65:301–8.PubMedCrossRef Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012;65:301–8.PubMedCrossRef
23.
go back to reference GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30. GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30.
24.
go back to reference Remely M, Hippe B, Geretschlaeger I, et al. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr. 2015;127:394–8.PubMedPubMedCentralCrossRef Remely M, Hippe B, Geretschlaeger I, et al. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr. 2015;127:394–8.PubMedPubMedCentralCrossRef
25.
go back to reference Celiberto LS, Graef FA, Healey GR, et al. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology. 2018;155:36–52.PubMedPubMedCentralCrossRef Celiberto LS, Graef FA, Healey GR, et al. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology. 2018;155:36–52.PubMedPubMedCentralCrossRef
28.
go back to reference Ma L, Dong W, Wang R, et al. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice. Brain Res Bull. 2015;116:67–72.PubMedCrossRef Ma L, Dong W, Wang R, et al. Effect of caloric restriction on the SIRT1/mTOR signaling pathways in senile mice. Brain Res Bull. 2015;116:67–72.PubMedCrossRef
29.
go back to reference Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15:2136–46.PubMedPubMedCentralCrossRef Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15:2136–46.PubMedPubMedCentralCrossRef
30.
go back to reference Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, et al. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol. 2012;47:1298–307.PubMedCrossRef Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, et al. Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J Gastroenterol. 2012;47:1298–307.PubMedCrossRef
31.
go back to reference Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685–93.PubMedPubMedCentralCrossRef Ott SJ, Musfeldt M, Wenderoth DF, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685–93.PubMedPubMedCentralCrossRef
32.
go back to reference Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183–9.PubMedCrossRef Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183–9.PubMedCrossRef
33.
go back to reference Sokol H, Lepage P, Seksik P, et al. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol. 2006;44:3172–7.PubMedPubMedCentralCrossRef Sokol H, Lepage P, Seksik P, et al. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol. 2006;44:3172–7.PubMedPubMedCentralCrossRef
34.
go back to reference Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.PubMedCrossRef Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.PubMedCrossRef
35.
go back to reference Huda-Faujan N, Abdulamir AS, Fatimah AB, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J. 2010;4:53–8.PubMedPubMedCentralCrossRef Huda-Faujan N, Abdulamir AS, Fatimah AB, et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J. 2010;4:53–8.PubMedPubMedCentralCrossRef
36.
go back to reference Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015;26(161):106–18.CrossRef Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015;26(161):106–18.CrossRef
37.
go back to reference Most J, Gilmore LA, Smith SR, Han H, Ravussin E, Redman LM. Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance. Am J Physiol Endocrinol Metab. 2018;314:E396–405.PubMedCrossRef Most J, Gilmore LA, Smith SR, Han H, Ravussin E, Redman LM. Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance. Am J Physiol Endocrinol Metab. 2018;314:E396–405.PubMedCrossRef
38.
go back to reference Fernando HA, Zibellini J, Harris RA, et al. Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. 2019;24(11):478.CrossRef Fernando HA, Zibellini J, Harris RA, et al. Effect of Ramadan fasting on weight and body composition in healthy non-athlete adults: a systematic review and meta-analysis. Nutrients. 2019;24(11):478.CrossRef
39.
go back to reference Jahrami HA, Alsibai J, Clark CCT, et al. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above. Eur J Nutr. 2020;59:2291–316.PubMedCrossRef Jahrami HA, Alsibai J, Clark CCT, et al. A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above. Eur J Nutr. 2020;59:2291–316.PubMedCrossRef
40.
go back to reference Jahrami HA, Faris ME, Janahi A, et al. Does four-week consecutive, dawn-to-sunset intermittent fasting during Ramadan affect cardiometabolic risk factors in healthy adults? A systematic review, meta-analysis, and meta-regression. Nutr Metab Cardiovasc Dis. 2021;31:2273–301.PubMedCrossRef Jahrami HA, Faris ME, Janahi A, et al. Does four-week consecutive, dawn-to-sunset intermittent fasting during Ramadan affect cardiometabolic risk factors in healthy adults? A systematic review, meta-analysis, and meta-regression. Nutr Metab Cardiovasc Dis. 2021;31:2273–301.PubMedCrossRef
41.
go back to reference Faris AE, Jahrami HA, Alsibai J, et al. Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis. Br J Nutr. 2020;14(123):1–22.CrossRef Faris AE, Jahrami HA, Alsibai J, et al. Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis. Br J Nutr. 2020;14(123):1–22.CrossRef
42.
go back to reference Faris M, Jahrami H, Abdelrahim D, Bragazzi N, et al. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2021;178: 108951.PubMedCrossRef Faris M, Jahrami H, Abdelrahim D, Bragazzi N, et al. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2021;178: 108951.PubMedCrossRef
43.
go back to reference Park Y, Park Y, Park S, Kim T, et al. Is fasting beneficial for hospitalized patients with inflammatory bowel diseases? Intest Res. 2020;18:85–95.PubMedCrossRef Park Y, Park Y, Park S, Kim T, et al. Is fasting beneficial for hospitalized patients with inflammatory bowel diseases? Intest Res. 2020;18:85–95.PubMedCrossRef
44.
go back to reference Goharifar H, Faezi S, Paragomi P, et al. The effect of Ramadan fasting on quiescent systemic lupus erythematosus (SLE) patients’ disease activity, health quality of life and lipid profile: a pilot study. Rheumatol Int. 2015;35:1409–14.PubMedCrossRef Goharifar H, Faezi S, Paragomi P, et al. The effect of Ramadan fasting on quiescent systemic lupus erythematosus (SLE) patients’ disease activity, health quality of life and lipid profile: a pilot study. Rheumatol Int. 2015;35:1409–14.PubMedCrossRef
45.
go back to reference Darch KM, Holland TL, Spelman LJ. Secukinumab-Induced inflammatory bowel disease in a patient treated for chronic plaque psoriasis and psoriatic arthritis: a case report and review of the role of novel biologic agents targeting the p19 subunit of IL-23. Case Rep Med. 2020;2020:9404505.PubMedPubMedCentralCrossRef Darch KM, Holland TL, Spelman LJ. Secukinumab-Induced inflammatory bowel disease in a patient treated for chronic plaque psoriasis and psoriatic arthritis: a case report and review of the role of novel biologic agents targeting the p19 subunit of IL-23. Case Rep Med. 2020;2020:9404505.PubMedPubMedCentralCrossRef
46.
go back to reference BaHammam AS, Almeneessier AS. Recent evidence on the impact of ramadan diurnal intermittent fasting, mealtime, and circadian rhythm on cardiometabolic risk: a review. Front Nutr. 2020;11(7):28.CrossRef BaHammam AS, Almeneessier AS. Recent evidence on the impact of ramadan diurnal intermittent fasting, mealtime, and circadian rhythm on cardiometabolic risk: a review. Front Nutr. 2020;11(7):28.CrossRef
47.
go back to reference Faris MAE, Jahrami HA, Alhayki FA, et al. Effect of diurnal fasting on sleep during Ramadan: a systematic review and meta-analysis. Sleep Breath. 2020;24:771–82.PubMedCrossRef Faris MAE, Jahrami HA, Alhayki FA, et al. Effect of diurnal fasting on sleep during Ramadan: a systematic review and meta-analysis. Sleep Breath. 2020;24:771–82.PubMedCrossRef
48.
go back to reference Al-Rawi N, Madkour M, Jahrami H, et al. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: a prospective observational study. PLoS ONE. 2020;26(15): e0237922.CrossRef Al-Rawi N, Madkour M, Jahrami H, et al. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: a prospective observational study. PLoS ONE. 2020;26(15): e0237922.CrossRef
49.
go back to reference Torres-Ruiz M, Sulli A, Cutolo M, et al. Air travel, circadian rhythms/hormones, and autoimmunity. Clin Rev Allerg Immunol. 2017;53:117–25.CrossRef Torres-Ruiz M, Sulli A, Cutolo M, et al. Air travel, circadian rhythms/hormones, and autoimmunity. Clin Rev Allerg Immunol. 2017;53:117–25.CrossRef
50.
go back to reference Faris MAE, Jahrami A, Obaideen A, et al. Impact of diurnal intermittent fasting during Ramadan on inflammatory and oxidative stress markers in healthy people: Systematic review and meta-analysis. J Nutr Intermed Metab. 2019;15:18–26.CrossRef Faris MAE, Jahrami A, Obaideen A, et al. Impact of diurnal intermittent fasting during Ramadan on inflammatory and oxidative stress markers in healthy people: Systematic review and meta-analysis. J Nutr Intermed Metab. 2019;15:18–26.CrossRef
51.
go back to reference Wang X, Yang Q, Liao Q, et al. Effects of intermittent fasting diets on plasma concentrations of inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Nutrition. 2020;79–80:110974.PubMedCrossRef Wang X, Yang Q, Liao Q, et al. Effects of intermittent fasting diets on plasma concentrations of inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Nutrition. 2020;79–80:110974.PubMedCrossRef
52.
go back to reference Atreya R, Neurath M. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187–96.PubMedCrossRef Atreya R, Neurath M. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol. 2005;28:187–96.PubMedCrossRef
53.
go back to reference Bjarnason I. The use of fecal calprotectin in inflammatory bowel disease. Gastroenterol Hepatol. 2017;13:53–6. Bjarnason I. The use of fecal calprotectin in inflammatory bowel disease. Gastroenterol Hepatol. 2017;13:53–6.
54.
go back to reference Hassanein M, Hussein Z, Shaltout I, et al. The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes. Diabetes Res Clin Pract. 2021;173: 108674.PubMedPubMedCentralCrossRef Hassanein M, Hussein Z, Shaltout I, et al. The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes. Diabetes Res Clin Pract. 2021;173: 108674.PubMedPubMedCentralCrossRef
55.
go back to reference Heun R. A systematic review on the effect of Ramadan on mental health: minor effects and no harm in general, but increased risk of relapse in schizophrenia and bipolar disorder. Global Psych. 2018;1(1):7–16. Heun R. A systematic review on the effect of Ramadan on mental health: minor effects and no harm in general, but increased risk of relapse in schizophrenia and bipolar disorder. Global Psych. 2018;1(1):7–16.
56.
go back to reference Akgul S, Derman O, Kanbur NA. Fasting during Ramadan: a religious factor as a possible trigger or exacerbator for eating disorders in adolescents. Int J Eat Disord. 2014;47:905–10.PubMedCrossRef Akgul S, Derman O, Kanbur NA. Fasting during Ramadan: a religious factor as a possible trigger or exacerbator for eating disorders in adolescents. Int J Eat Disord. 2014;47:905–10.PubMedCrossRef
57.
58.
go back to reference Eddahby S, Kadri N. Moussaoui D Fasting during Ramadan isassociated with a higher recurrence rate in patients with bipolar disorder. World Psychiatry. 2014;13:97.PubMedPubMedCentralCrossRef Eddahby S, Kadri N. Moussaoui D Fasting during Ramadan isassociated with a higher recurrence rate in patients with bipolar disorder. World Psychiatry. 2014;13:97.PubMedPubMedCentralCrossRef
59.
go back to reference Chicco F, Magrì S, Cingolani A, et al. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021;1(27):1–9.CrossRef Chicco F, Magrì S, Cingolani A, et al. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021;1(27):1–9.CrossRef
60.
Metadata
Title
Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study
Authors
Mohamed Negm
Ahmed Bahaa
Ahmed Farrag
Rania M. Lithy
Hedy A. Badary
Mahmoud Essam
Shimaa Kamel
Mohamed Sakr
Waleed Abd El Aaty
Mostafa Shamkh
Ahmed Basiony
Ibrahim Dawoud
Hany Shehab
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2022
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-022-02272-3

Other articles of this Issue 1/2022

BMC Gastroenterology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine